3 YEAR FOLLOW-UP DATA ON THE LIPID-LOWERING EFFECTS OF NICOTINIC-ACID AND LOVASTATIN IN RENAL-TRANSPLANT PATIENTS

被引：0
|
作者：
LAL, SM [1 ]
PETROSKI, GF [1 ]
HEWETT, JE [1 ]
VANSTONE, JC [1 ]
ROSS, G [1 ]
机构：
[1] UNIV MISSOURI,DEPT INTERNAL MED,COLUMBIA,MO
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1995年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1100 / 1100
页数：1
相关论文
共 50 条
  • [21] Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI
    Yonemura, Atsushi
    Momiyama, Yukihiko
    Fayad, Zahi A.
    Ayaori, Makoto
    Ohmori, Reiko
    Kihara, Teruyoshi
    Tanaka, Nobukiyo
    Nakaya, Kazuhiro
    Ogura, Masatsune
    Taniguichi, Hiroaki
    Kusuhara, Masatoshi
    Nagata, Masayoshi
    Nakamura, Haruo
    Tamai, Seiichi
    Ohsuzu, Fumitaka
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (02): : 222 - 228
  • [22] CONSENSUS PANEL ABOUT IMPLEMENTATION OF GUIDELINES ON LIPID-LOWERING MANAGEMENT AFTER ACUTE CORONARY SYNDROME AND UP TO ONE YEAR FOLLOW-UP
    Basaran, O.
    Ozdogan, O.
    Kayikcioglu, M.
    Gungor, B.
    Ceyhan, C.
    Selvi, M.
    Kus, M.
    Tokgozoglu, L.
    ATHEROSCLEROSIS, 2023, 379 : S81 - S82
  • [23] CYCLOSPORINE VERSUS AZATHIOPRINE - A 5-YEAR FOLLOW-UP OF 200 CONSECUTIVE CADAVER RENAL-TRANSPLANT RECIPIENTS
    SLATON, JW
    KROPP, KA
    JHUNJHUNWALA, JS
    SELMAN, SH
    JOURNAL OF UROLOGY, 1994, 151 (03): : 582 - 585
  • [24] EARLY AND LATE COMPLICATIONS OF CYCLOSPORINE TREATMENT IN A 5-YEAR FOLLOW-UP OF 250 RENAL-TRANSPLANT RECIPIENTS
    CIVATI, G
    BUSNACH, G
    PERRINO, ML
    BROGGI, ML
    BRANDO, B
    SEVESO, M
    MINETTI, L
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1571 - 1572
  • [25] Endothelial Response, Parathyroid Hormone and Homocysteine in Renal Transplant Recipients: 3-Year Follow-Up Data
    Zanazzi, M.
    Fatini, C.
    Sticchi, E.
    Cioni, G.
    Rossi, L.
    Liotta, A. Alessandrello
    Buti, E.
    Carta, P.
    Larti, A.
    Minetti, E.
    Abbate, R.
    TRANSPLANTATION, 2014, 98 : 528 - 528
  • [26] INTEREST IN AND LIMITATIONS OF MONOCLONAL ANTI-T-CELL ANTIBODIES FOR THE FOLLOW-UP OF RENAL-TRANSPLANT PATIENTS
    CHATENOUD, L
    CHKOFF, N
    KREIS, H
    BACH, JF
    TRANSPLANTATION, 1983, 36 (01) : 45 - 50
  • [27] The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK
    Sever, Peter S.
    Chang, Choon L.
    Gupta, Ajay K.
    Whitehouse, Andrew
    Poulter, Neil R.
    EUROPEAN HEART JOURNAL, 2011, 32 (20) : 2525 - 2532
  • [28] CHANGES OF EXCESS BODY WEIGHT IN CHILDREN WITH DYSLIPIDEMIAS ON LIPID-LOWERING DIETARY THERAPY DURING A TWO-YEAR FOLLOW-UP
    Bruno, V.
    Terrone, G.
    Tucci, F.
    Quitadamo, P.
    Greco, L.
    Malamisura, B.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S333 - S333
  • [29] Effects of lipid-lowering by simivastatin on human atherosclerotic lesions: 2 years follow-up by high-resolution MRI
    Corti, R
    Fayad, ZA
    Fuster, V
    Warthley, S
    Helft, G
    Weinberger, J
    Chesebro, J
    Mercuri, M
    Badimon, JJ
    CIRCULATION, 2001, 104 (17) : 375 - 375
  • [30] Lipid-lowering efficacy and safety of varying doses of Simvastatin in patients with early stage acute coronary syndromes: one-year follow-up study
    Zou, YC
    Hu, DY
    Yang, XC
    Xu, ZM
    Cui, LA
    Liu, XH
    Wei, Y
    Gao, MM
    CHINESE MEDICAL JOURNAL, 2003, 116 (06) : 853 - 856
12345